Abstract: The present invention provides an aminopyrazole compound, or a pharmaceutically acceptable salt thereof or a solvate of the salt, that inhibits Chk1 and is useful in the treatment of cancer.
PLEASE SEE THE SPECIFICATION ATTACHED.
| # | Name | Date |
|---|---|---|
| 1 | 4123-CHENP-2011 FORM-18 17-06-2011.pdf | 2011-06-17 |
| 1 | 4123-CHENP-2011-RELEVANT DOCUMENTS [29-01-2019(online)].pdf | 2019-01-29 |
| 2 | 4123-CHENP-2011 CORRESPONDENCE OTHERS 17-06-2011.pdf | 2011-06-17 |
| 2 | 4123-CHENP-2011-RELEVANT DOCUMENTS [18-01-2018(online)].pdf | 2018-01-18 |
| 3 | Correspondence by Agent_Power Of Attorney_26-12-2017.pdf | 2017-12-26 |
| 3 | 4123-CHENP-2011 FORM-13 17-06-2011.pdf | 2011-06-17 |
| 4 | 4123-CHENP-2011-IntimationOfGrant21-12-2017.pdf | 2017-12-21 |
| 4 | 4123-CHENP-2011 CORRESPONDENCE OTHERS 17-06-2011.pdf | 2011-06-17 |
| 5 | 4123-CHENP-2011-PatentCertificate21-12-2017.pdf | 2017-12-21 |
| 5 | 4123-CHENP-2011 AMENDED CLAIMS 17-06-2011.pdf | 2011-06-17 |
| 6 | Abstract_Granted 290940_21-12-2017.pdf | 2017-12-21 |
| 6 | 4123-CHENP-2011 CORRESPONDENCE OTHERS 13-07-2011.pdf | 2011-07-13 |
| 7 | Form-5.pdf | 2011-09-04 |
| 7 | Claims_Granted 290940_21-12-2017.pdf | 2017-12-21 |
| 8 | Form-3.pdf | 2011-09-04 |
| 8 | Description Complete_Granted 290940_21-12-2017.pdf | 2017-12-21 |
| 9 | 4123-CHENP-2011-FORM-26 [14-12-2017(online)].pdf | 2017-12-14 |
| 9 | Form-1.pdf | 2011-09-04 |
| 10 | 4123-CHENP-2011 FORM-3 13-12-2011.pdf | 2011-12-13 |
| 10 | 4123-CHENP-2011-Annexure [08-12-2017(online)].pdf | 2017-12-08 |
| 11 | 4123-CHENP-2011 CORRESPONDENCE OTHERS 13-12-2011.pdf | 2011-12-13 |
| 11 | 4123-CHENP-2011-CLAIMS [08-12-2017(online)].pdf | 2017-12-08 |
| 12 | 4123-CHENP-2011 FORM-13 14-05-2015.pdf | 2015-05-14 |
| 12 | 4123-CHENP-2011-FER_SER_REPLY [08-12-2017(online)].pdf | 2017-12-08 |
| 13 | 4123-CHENP-2011-OTHERS [08-12-2017(online)].pdf | 2017-12-08 |
| 13 | Form 13.pdf | 2015-05-18 |
| 14 | 4123-CHENP-2011-FER.pdf | 2017-06-09 |
| 14 | Form 1.pdf | 2015-05-18 |
| 15 | 4123-CHENP-2011-FER.pdf | 2017-06-09 |
| 15 | Form 1.pdf | 2015-05-18 |
| 16 | 4123-CHENP-2011-OTHERS [08-12-2017(online)].pdf | 2017-12-08 |
| 16 | Form 13.pdf | 2015-05-18 |
| 17 | 4123-CHENP-2011-FER_SER_REPLY [08-12-2017(online)].pdf | 2017-12-08 |
| 17 | 4123-CHENP-2011 FORM-13 14-05-2015.pdf | 2015-05-14 |
| 18 | 4123-CHENP-2011 CORRESPONDENCE OTHERS 13-12-2011.pdf | 2011-12-13 |
| 18 | 4123-CHENP-2011-CLAIMS [08-12-2017(online)].pdf | 2017-12-08 |
| 19 | 4123-CHENP-2011 FORM-3 13-12-2011.pdf | 2011-12-13 |
| 19 | 4123-CHENP-2011-Annexure [08-12-2017(online)].pdf | 2017-12-08 |
| 20 | 4123-CHENP-2011-FORM-26 [14-12-2017(online)].pdf | 2017-12-14 |
| 20 | Form-1.pdf | 2011-09-04 |
| 21 | Description Complete_Granted 290940_21-12-2017.pdf | 2017-12-21 |
| 21 | Form-3.pdf | 2011-09-04 |
| 22 | Claims_Granted 290940_21-12-2017.pdf | 2017-12-21 |
| 22 | Form-5.pdf | 2011-09-04 |
| 23 | 4123-CHENP-2011 CORRESPONDENCE OTHERS 13-07-2011.pdf | 2011-07-13 |
| 23 | Abstract_Granted 290940_21-12-2017.pdf | 2017-12-21 |
| 24 | 4123-CHENP-2011 AMENDED CLAIMS 17-06-2011.pdf | 2011-06-17 |
| 24 | 4123-CHENP-2011-PatentCertificate21-12-2017.pdf | 2017-12-21 |
| 25 | 4123-CHENP-2011-IntimationOfGrant21-12-2017.pdf | 2017-12-21 |
| 25 | 4123-CHENP-2011 CORRESPONDENCE OTHERS 17-06-2011.pdf | 2011-06-17 |
| 26 | Correspondence by Agent_Power Of Attorney_26-12-2017.pdf | 2017-12-26 |
| 26 | 4123-CHENP-2011 FORM-13 17-06-2011.pdf | 2011-06-17 |
| 27 | 4123-CHENP-2011-RELEVANT DOCUMENTS [18-01-2018(online)].pdf | 2018-01-18 |
| 27 | 4123-CHENP-2011 CORRESPONDENCE OTHERS 17-06-2011.pdf | 2011-06-17 |
| 28 | 4123-CHENP-2011-RELEVANT DOCUMENTS [29-01-2019(online)].pdf | 2019-01-29 |
| 28 | 4123-CHENP-2011 FORM-18 17-06-2011.pdf | 2011-06-17 |
| 1 | PatSeer_19-01-2017.pdf |